ASUUY(ASUUY)
ASUUY
No analyst ratings available
No analyst price targets available for ASUUY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $993.15B | $1.20T | $1.32T |
| Low | $936.17B | $1.04T | $1.19T |
| High | $1.06T | $1.37T | $1.46T |
| EBITDA Avg | $82.51B | $83.00B | $87.06B |
| Low | $72.40B | $72.86B | $76.45B |
| High | $93.25B | $93.76B | $98.33B |
| EBIT Avg | $79.33B | $79.49B | $83.20B |
| Low | $69.21B | $69.36B | $72.59B |
| High | $90.07B | $90.26B | $94.48B |
| Net Income Avg | $58.71B | $58.83B | $61.61B |
| Low | $51.15B | $51.26B | $53.67B |
| High | $66.74B | $66.88B | $70.04B |
| EPS Avg | $365.23 | $366.00 | $383.26 |
| Low | $318.18 | $318.85 | $333.89 |
| High | $415.19 | $416.06 | $435.69 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $281.77B | $266.25B | $270.80B | $296.97B | $336.11B | $326.65B |
| Low | $263.38B | $226.77B | $242.26B | $265.66B | $300.68B | $292.22B |
| High | $290.22B | $326.08B | $304.42B | $333.84B | $377.84B | $367.21B |
| EBITDA Avg | $22.56B | $18.21B | $18.35B | $20.80B | $23.50B | $18.71B |
| Low | $19.64B | $15.89B | $16.01B | $18.12B | $20.45B | $16.32B |
| High | $26.00B | $20.95B | $21.11B | $23.95B | $27.08B | $21.52B |
| EBIT Avg | $21.67B | $17.31B | $17.44B | $19.87B | $22.56B | $17.75B |
| Low | $18.75B | $14.99B | $15.10B | $17.20B | $19.51B | $15.36B |
| High | $25.11B | $20.05B | $20.20B | $23.03B | $26.14B | $20.56B |
| Net Income Avg | $15.95B | $12.69B | $12.79B | $14.60B | $16.61B | $13.02B |
| Low | $13.76B | $10.95B | $11.03B | $12.60B | $14.33B | $11.23B |
| High | $18.52B | $14.74B | $14.85B | $16.96B | $19.29B | $15.12B |
| EPS Avg | $106.93 | $85.10 | $85.74 | $97.94 | $111.38 | $87.29 |
| Low | $92.28 | $73.44 | $73.99 | $84.52 | $96.12 | $75.32 |
| High | $124.19 | $98.84 | $99.58 | $113.74 | $129.35 | $101.37 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 3 / 1 | 3 / 1 | 3 / 1 | 6 / 1 |